Cargando…
Cost-Effectiveness of Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease: A Systematic Review
Infliximab and adalimumab are monoclonal antibodies against tumor necrosis factor (anti-TNF) used to manage inflammatory bowel disease (IBD). Therapeutic Drug Monitoring (TDM) has been proven to prevent immunogenicity, to achieve better long-term clinical results and to save costs in IBD treatment....
Autores principales: | Marquez-Megias, Silvia, Nalda-Molina, Ricardo, Sanz-Valero, Javier, Más-Serrano, Patricio, Diaz-Gonzalez, Marcos, Candela-Boix, Maria Remedios, Ramon-Lopez, Amelia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145467/ https://www.ncbi.nlm.nih.gov/pubmed/35631594 http://dx.doi.org/10.3390/pharmaceutics14051009 |
Ejemplares similares
-
Evaluation of the Predictive Performance of Population Pharmacokinetic Models of Adalimumab in Patients with Inflammatory Bowel Disease
por: Marquez-Megias, Silvia, et al.
Publicado: (2021) -
Population Pharmacokinetic Model of Adalimumab Based on Prior Information Using Real World Data
por: Marquez-Megias, Silvia, et al.
Publicado: (2023) -
Systematic review: genetic biomarkers associated with anti‐TNF treatment response in inflammatory bowel diseases
por: Bek, S., et al.
Publicado: (2016) -
Changes in Anthropometric Parameters After Anti-TNFα Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
por: Mazhar, Faizan, et al.
Publicado: (2020) -
Disorders Induced by Direct Occupational Exposure to Noise: Systematic Review
por: Domingo-Pueyo, Andrea, et al.
Publicado: (2016)